Meeting
2016 ASCO Annual Meeting
Sequential Boost Versus integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer (LAHNC).
Authors
Anthony Cmelak
Vanderbilt-Ingram Cancer Center, Nashville, TN
Anthony Cmelak , Mark J. Stavas , Barbara A. Murphy , Yu Shyr , Jill Gilbert , Sheau-Chiann Chen , Gregory Vlacich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6070)
DOI
10.1200/JCO.2016.34.15_suppl.6070
Abstract #
6070
Poster Bd #
392
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2013 ASCO Annual Meeting
A phase II study of radiation therapy (RT), paclitaxel poliglumex (PPX), and cetuximab (C) in locally advanced head and neck cancer (LA-HNC).
First Author: Seung Shin Hahn
Poster
2023 ASCO Annual Meeting
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade glioma patients: OLA-TMZ-RTE-01.
First Author: Dinu Stefan
Poster
2020 Genitourinary Cancers Symposium
Treatment compliance and early toxicity in SAKK 01/10: Single-dose carboplatin and involved-node radiotherapy for treatment of stage IIA/B seminoma.
First Author: Alexandros Papachristofilou